Quarterly report pursuant to Section 13 or 15(d)

Restatement of Condensed Consolidated Financial Statements (Tables)

v3.22.1
Restatement of Condensed Consolidated Financial Statements (Tables)
 6 Months Ended
Sep. 30, 2021
Accounting Changes and Error Corrections [Abstract]  
Summary of Restatement Impact
Three months ended September 30, 2021 Six months ended September 30, 2021
Reported Adjustment Restated Reported Adjustment Restated
Net revenues $ 310,205 $ (121,637) $ 188,568 $ 522,820 $ (176,177) $ 346,643
Costs of revenues and operating expenses
License fees and revenue share 213,145 (121,637) 91,508 351,493 (176,177) 175,316
Other direct costs of revenues 3,838 3,989 7,827 6,371 5,924 12,295
Product development 17,904 (3,989) 13,915 33,451 (6,612) 26,839
Sales and marketing 17,479 — 17,479 31,215 — 31,215
General and administrative 41,307 — 41,307 64,613 688 65,301
Total costs of revenues and operating expenses 293,673 172,036 487,143 310,966
Income from operations $ 16,532 $ 16,532 $ 35,677 $ 35,677